GLP-1, creatine and muscle mass: what the science shows

Three topics recur in sports science and metabolic health discussions more than almost any other: GLP-1 receptor agonists, creatine supplementation, and muscle memory. Each comes with a body of evidence that often conflicts with popular claims. This post covers what the research actually shows.

GLP-1 receptor agonists and muscle loss

GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) produce substantial weight loss in most patients. The concern is that a significant portion of that weight is lean muscle mass. In the STEP trials, roughly 40% of the weight lost by participants taking semaglutide came from lean mass, not fat. This ratio is worse than what is typically seen with diet-induced weight loss in the absence of medication.

The mechanism is not fully understood, but several factors likely contribute. GLP-1 agonists reduce appetite broadly, which leads to a large caloric deficit. In that deficit, without sufficient protein intake and resistance training, the body draws on muscle protein for energy. The drugs may also reduce the anabolic signaling associated with food intake itself, independent of calorie reduction.

The practical implication: people taking GLP-1 agonists for weight loss should prioritize protein intake (at least 1.6 g/kg of body weight per day) and resistance training throughout the course of treatment, not just after stopping the medication.

What DEXA scans do and don't measure

DEXA (dual-energy X-ray absorptiometry) is the clinical standard for measuring body composition: fat mass, lean mass, and bone density. It is accurate and reproducible. But DEXA measures total lean mass in a given region, not contractile muscle specifically. Lean mass includes water, glycogen stores, connective tissue, and intramuscular fat, in addition to actual muscle fiber.

This matters when interpreting results. A person who has recently trained and whose glycogen stores are full will show higher lean mass on DEXA than the same person tested after a few days of reduced carbohydrate intake. The number changes without any change in actual muscle fiber content. Similarly, a patient taking GLP-1 agonists who loses lean mass on DEXA may be losing water and glycogen alongside muscle protein, but the DEXA scan cannot distinguish between these components.

The gold standard for measuring actual muscle volume is MRI, which can differentiate muscle fiber from fat and connective tissue. For clinical purposes, DEXA remains useful as a directional tool, but single measurements should be interpreted with caution.

Creatine: mechanism and evidence

Creatine monohydrate is the most studied performance supplement in sports science. It works by replenishing phosphocreatine stores in muscle, enabling faster ATP regeneration during high-intensity exercise. This leads to modest but consistent improvements in power output, particularly in short-duration, high-intensity efforts.

Beyond performance, creatine has a well-documented anabolic effect. It increases the water content inside muscle cells (cell volumization), which triggers anabolic signaling pathways. It also reduces markers of muscle damage and inflammation after exercise, accelerating recovery.

Several meta-analyses confirm that creatine supplementation adds approximately 1-2 kg of lean mass over 4-12 weeks compared to placebo, when combined with resistance training. The effect is real, measurable, and independent of the cell volumization component.

The dosing is straightforward: 3-5 g of creatine monohydrate per day, taken consistently. A loading phase (20 g/day for 5-7 days) saturates stores faster but produces the same long-term result as a standard daily dose. Timing relative to workouts appears to matter less than consistency.

Muscle memory: the epigenetic mechanism

Muscle memory refers to the observation that previously trained individuals regain strength and muscle mass faster than beginners when they resume training after a period of detraining. The phenomenon is real and has been documented across multiple species and training protocols.

The mechanism was unclear for many years. Recent evidence points to epigenetic changes: myonuclei (the nuclei within muscle fibers) persist after muscle atrophy. When muscle is built through resistance training, satellite cells fuse with existing fibers and donate their nuclei. These extra nuclei remain even when the muscle shrinks during detraining. When training resumes, the additional nuclei accelerate the reactivation of muscle protein synthesis, enabling faster regrowth.

A complementary mechanism involves DNA methylation patterns in muscle tissue. Training induces specific methylation changes at genes related to muscle protein synthesis and metabolic adaptation. Some of these changes appear to persist through periods of inactivity, acting as an epigenetic record of prior training.

The clinical implication is straightforward: training history matters. People who have trained seriously at any point in their lives retain a biological advantage when they resume training, even after years of inactivity. This is not just motivation; it is a structural, cellular phenomenon.

Practical summary

For anyone taking GLP-1 agonists: resistance training and adequate protein are not optional add-ons. They are the primary tools for preserving the lean mass the medication puts at risk.

For anyone using DEXA to track body composition: trends over multiple scans matter more than any single measurement. Standardize testing conditions (same hydration state, same time relative to last meal and exercise) to improve comparability between sessions.

For anyone considering creatine: the evidence is robust, the cost is low, and the safety profile over decades of research is excellent. Start with 3-5 g daily and maintain consistency.

Conclusion

The science around GLP-1 drugs, body composition measurement, and supplementation is clearer than the popular discourse suggests. Muscle loss during GLP-1 therapy is real and preventable with the right approach. DEXA is a useful but imprecise tool. Creatine works through well-understood mechanisms. And the muscle you built years ago has left a lasting biological imprint that works in your favor when you return to training.